patient treatment News
-
Showcase
RTsafe’s core role for the development of German guidelines for a standard, safe and efficient implementation of Single-Isocentric Multi-Focal SRS throughout the country
RTsafe is happy to announce that its PRIME and Pseudopatient 3D phantoms, have been selected by a consortium of high-end German Radiotherapy Institutions – led by the Division of Medical Physics of the Department of Radiation Oncology at the Medical Center of University of Freiburg – towards supporting a study whose results will be used for the development of national guidelines in ...
By RTsafe
-
Micro Device offers Low Intensity SW Therapy suitable for Home and Mobile Treatment
An exclusive and limited offer is presently being offered to clinics interested in offering treatment. Demo proposal is for a three month period and incorporates minimum 10 patient treatments, of 10 short sessions in 5 days, and follow-up p/p. Micro is the latest MoreNova model, offering patented Large Area Shockwave Technology for treating medical and cosmetic conditions. A small, light and ...
By DirexGroup
-
medPhoton’s ImagingRing technology in clinical use at Maastro Clinic
medPhoton’s ceiling mounted ImagingRing integrated to the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning at Zuid-Oost Nederland Protonen Therapie Centrum, (ZON-PTC) at the MAASTRO Clinic in Maastricht, the Netherlands. Patient treatment has begun on February 8, 2019 as a result of a close collaboration between Mevion, Maastro Clinic and medPhoton. “Proton ...
-
TAE Life Sciences Partners with BEC to Incorporate Specialized Robotic Patient Positioning System in its Alphabeam System for High-Precision Boron Neutron Capture Therapy
TAE Life Sciences (TLS), a biological-targeting radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced a partnership with BEC GmbH (BEC) to incorporate a customized, robotic patient positioning system as part of its Alphabeam™ Neutron System for the high-precision radiation treatment of tumors. During BNCT, it is essential that the ...
-
First Simulated Patient Treatment Carried Out in the First Hospital-Based BNCT Facility in Europe
BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the world’s leading provider of control systems for the planet’s most complex machines, today announced that Neutron Therapeutics' nuBeam® BNCT System, using Cosylab's OncologyOne ...
-
Showcase
Primary Results of Onawa (Solti-1802) Trial: A Window Of Opportunity Trial Of Onapristone In Postmenopausal Women With Progesterone Receptor-Positive/Her2-Negative Early Breast Cancer
PGR is an estrogen-responsive gene and progesterone receptor (PR) expression, evaluated by immunohistochemistry (IHC), is used as a clinical biomarker of estrogen signaling and estrogen receptor (ER) functionality.1 Despite the well-studied role of PGR as mitogen and independent ER activator, anti-progestins for the treatment of BC have been poorly tested. While limited success for ...
-
Aidoc And Screenpoint Medical Announce Partnership To Provide Complete Ai Solution For Breast Imaging
Aidoc’s comprehensive AI continues to expand to cover the majority of radiology adult subspecialties Aidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and 3D mammography, today announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging specialists will now be ...
By Aidoc
-
Aidoc And Riverain Technologies Partner To Streamline Access To Time Saving Chest Ai Solutions
Partnership provides a seamless workflow to improve patient outcomes while enabling radiologists to read faster with commercially available solutions. Aidoc and Riverain Technologies, two leading providers of AI for medical imaging, announced a new collaboration today. This new partnership will improve provider access to both solutions by incorporating Riverain’s commercially available ...
By Aidoc
-
Aidoc launches the first ai-based automated notification solution for high-risk pulmonary embolism patients
Aidoc, the leading provider of enterprise AI solutions, announced today the launch of an industry first: an AI-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. Aidoc’s PE Care Coordination includes Aidoc’s FDA-cleared solution for triage and notification of PE. The solution is ...
By Aidoc
-
Showcase
Corify Care Participates In the Atrial Signals Workshop 2021
Last week (23-25th September) took place the workshop Atrial Signals 2021 http://www.atrial-signals.kit.edu/ at the Karlsruhe Institute of Technology (KIT), thanks to the joint collaboration of the Institute of Biomedical Engineering (IBT) and the Städtisches Klinikum Karlsruhe. Andreu Climent, CEO of Corify Care presented Acorys, our Non-invasive Electrocardiographic Imaging device of the ...
-
BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform
TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced hospitals and other healthcare facilities utilizing InMotion Connect™ have seen a 72% increase in ...
By Bionik
-
CoreMap Wins National Science Foundation Phase 1 SBIR Award
CoreMap, Inc. announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF) to support development of its technology aimed at expanding treatment opportunities for patients with Atrial Fibrillation (AF). AF is the most common and complex cardiac arrythmia affecting 33 million patients globally where patients are at ...
By CoreMap Inc.
-
tiakis (formerly Proteo Biotech AG) Elafin Enters the Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension
tiakis BIOTECH AG today announced the start of the clinical development for the subcutaneous use of tiakis lead investigational drug candidate Elafin (INN: Tiprelestat). The Duke University Early Phase Research Unit initiated the recruitment of healthy individuals for the Phase I clinical trial in the U.S. to assess the safety and tolerability of repeated single doses of Elafin. tiakis research ...
-
tiakis receives GLP Certificate from Competent Authority
tiakis BIOTECH AG today announced that the competent Good Laboratory Practice (GLP) Monitoring Authority of the German State of Schleswig-Holstein (State Office for Agriculture, Environment and Rural Areas of the Land Schleswig-Holstein) has performed a GLP inspection resulting in the confirmation that tiakis test site is able to conduct the archiving of documents related to in-house development ...
-
VMI Raises more than 86,000 Euro with Stelvio for Life
A team of 47 VMI colleagues from Epe and Leszno participated in the Stelvio for Life challenge on Saturday, September 3rd. With this, they raised over 86,000 Euros in the fight against cancer. VMI Raises Funds for Cancer Charity Each year, VMI participates in a challenging sporting event to raise money for charity. After 2 years of not being able to participate in such a fund aising event, the ...
-
Aidoc Showcases Full Ai Care Coordination Suite At International Stroke Conference 2022
AI-powered neuroscience solutions for intracranial hemorrhage, ischemic stroke, cervical spine fractures, on display at ISC 2022, New Orleans, February 9-11, Booth #801 New York, February 8, 2022 – Aidoc, the leading provider of healthcare AI solutions, will be delivering a live demonstration of its comprehensive AI care coordination suite at ISC 2022, February 9-11, in New Orleans, Booth ...
By Aidoc
-
Patent for Cell Selection of Beta Cells to Treat and Potentially Cure Diabetes was Granted in Japan
Ness Ziona, Israel, July, 2021 --- Cell therapy company Kadimastem Ltd (TASE: KDST) has received its patent approval from the Japanese Patent Office for IsletRx, the company’s innovative treatment for diabetes. IsletRx comprises an expanded population of clinical grade pancreatic islet-like cluster (ILCs) cells, derived from human stem cells, that have the ability to secrete insulin when ...
-
Tactile Medical Announces Publication of Expert Opinion Consensus Statement in Phlebology Recommending the Use of Pneumatic Compression for Lymphedema
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the publication of an expert opinion consensus statement. Three independent societies’ consensus endorsements were published in peer-reviewed Phlebology: ...
-
Showcase
Corify Care raises €2.35M to translate its cardiac mapping technology to the market. .
- Corify Care is developing ACORYS®, a non-invasive cardiac mapping medical device to transform the cardiac arrhythmia treatment process. - The investment round is led by Clave Capital, counting with investment from CDTI through its Innvierte program and the support from Genesis Biomed. Corify Care, the developer of an innovative and completely non-invasive cardiac mapping system, ...
-
Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 12-month results from a Level 1, prospective, randomized, multi-center trial that demonstrated the effectiveness and superiority of the Intracept® Procedure for vertebrogenic CLBP compared to standard care treatments. The INTRACEPT study randomized 140 ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you